Duchenne Muscular Dystrophy

Drug Name: Agamree Active Ingredient: vamorolone Indication: To treat Duchenne muscular dystrophy Approval Date: 10/26/2023 Company: Santhera Pharmaceuticals (USA), Inc More: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215239s000lbl.pdf

Tradename: ELEVIDYS Proper Name: delandistrogene moxeparvovec-rokl Indication: Indicated for treatment of ambulatory pediatric patients aged 4 through 5 years with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the…